What Changed
Price Move History
- Daily moves over 5%
- 0 19 sessions, January 28, 2025 to February 11, 2026
- Largest daily move
- +0% close of February 14, 2025
- 1-year change
- +0% closing prices, January 28, 2025 to February 11, 2026
Company Description
RENNOVA HEALTH (OTC: RNVA) is classified in the diagnostics & research industry within the Healthcare sector and carries a market capitalization of $4.3M.
RNVA has gained 0.0% over the past year. The last closing price was $0.0001.
This page collects what Stock Titan holds for RNVA, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
RENNOVA HEALTH (RNVA) closed at $0.0001 on February 11, 2026. Over the past 12 months, the price has gained 0.0%.
RNVA Metrics & Rankings
Price returns through February 11, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
RENNOVA HEALTH has 10 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all RNVA news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in RENNOVA HEALTH (RNVA) currently stands at 3 shares.
Days to Cover History
Days to cover for RENNOVA HEALTH (RNVA) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
RNVA Company Profile & Sector Positioning
RENNOVA HEALTH (RNVA) operates in the Diagnostics & Research industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing RNVA often look at related companies in the same sector, including IMD COMPANIES INC (ICBU), HYPHA LABS, INC. (FUNI), LEVELJUMP HEALTHCARE CP (JMPHF), INTERPACE BIOSCIENCES NEW (IDXG), and STAGEZERO LIFE SCIENCES (SZLSF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate RNVA's relative position within its industry.